These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26823776)

  • 21. PRAME gene expression in childhood acute lymphoblastic leukemia: impact on prognosis.
    Abdelmalak CA; Yahya RS; Elghannam DM; El-Khadragy AE; Abd El Messih HM
    Clin Lab; 2014; 60(1):55-61. PubMed ID: 24600975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling.
    Epping MT; Wang L; Edel MJ; Carlée L; Hernandez M; Bernards R
    Cell; 2005 Sep; 122(6):835-47. PubMed ID: 16179254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PRAME, a gene encoding an antigen recognized on a human melanoma by cytolytic T cells, is expressed in acute leukaemia cells.
    van Baren N; Chambost H; Ferrant A; Michaux L; Ikeda H; Millard I; Olive D; Boon T; Coulie PG
    Br J Haematol; 1998 Sep; 102(5):1376-9. PubMed ID: 9753074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [PRAME mRNA expression in newly diagnosed acute myeloid leukemia patients and its application to monitoring minimal residual disease].
    Qin YZ; Li JL; Zhu HH; Li LD; Chang Y; Hao L; Wang YZ; Jiang B; Lu XJ; Liu YR; Huang XJ; Chen SS
    Zhonghua Xue Ye Xue Za Zhi; 2008 Jul; 29(7):441-5. PubMed ID: 19035174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PLZF-mediated control on c-kit expression in CD34(+) cells and early erythropoiesis.
    Spinello I; Quaranta MT; Pasquini L; Pelosi E; Petrucci E; Pagliuca A; Castelli G; Mariani G; Diverio D; Foà R; Testa U; Labbaye C
    Oncogene; 2009 Jun; 28(23):2276-88. PubMed ID: 19421145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Role of MG132, a proteasome inhibitor, in inducing expression of costimulatory molecules CD86 in leukemic cells and its effect on allogeneic mixed lymphocyte reaction].
    Zhou YM; Guo W; Xue KY; Zhou H; Cheng YX; Guo TN; Li HY; Huang SA
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):710-3. PubMed ID: 17553313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PRAME-induced inhibition of retinoic acid receptor signaling-mediated differentiation--a possible target for ATRA response in AML without t(15;17).
    Bullinger L; Schlenk RF; Götz M; Botzenhardt U; Hofmann S; Russ AC; Babiak A; Zhang L; Schneider V; Döhner K; Schmitt M; Döhner H; Greiner J
    Clin Cancer Res; 2013 May; 19(9):2562-71. PubMed ID: 23444226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia.
    Santamaría C; Chillón MC; García-Sanz R; Balanzategui A; Sarasquete ME; Alcoceba M; Ramos F; Bernal T; Queizán JA; Peñarrubia MJ; Giraldo P; San Miguel JF; Gonzalez M
    Haematologica; 2008 Dec; 93(12):1797-805. PubMed ID: 18815192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia.
    Atanackovic D; Luetkens T; Kloth B; Fuchs G; Cao Y; Hildebrandt Y; Meyer S; Bartels K; Reinhard H; Lajmi N; Hegewisch-Becker S; Schilling G; Platzbecker U; Kobbe G; Schroeder T; Bokemeyer C; Kröger N
    Am J Hematol; 2011 Nov; 86(11):918-22. PubMed ID: 21898529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preferentially expressed antigen of melanoma (PRAME) in the development of diagnostic and therapeutic methods for hematological malignancies.
    Matsushita M; Yamazaki R; Ikeda H; Kawakami Y
    Leuk Lymphoma; 2003 Mar; 44(3):439-44. PubMed ID: 12688312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leucine-rich repeat protein PRAME: expression, potential functions and clinical implications for leukaemia.
    Wadelin F; Fulton J; McEwan PA; Spriggs KA; Emsley J; Heery DM
    Mol Cancer; 2010 Aug; 9():226. PubMed ID: 20799951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mechanism of lithium chloride-induced proliferation inhibition and apoptosis of K562 leukemic cells].
    Tang HR; He Q; Wang FC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):979-82. PubMed ID: 16403263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunotherapy in Acute Leukemias: Implications and Perspectives Using Wt1 Antigen.
    Cebinelli GC; DE Sousa Pereira N; Sena MM; DE Oliveira CE; Fujita TC; DA Rocha SP; DE Abreu Oliveira FJ; Marinello PC; Watanabe MA
    Anticancer Res; 2016 Aug; 36(8):3795-802. PubMed ID: 27466479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The experimental study of transfected sFlt-Ig gene on K562 leukemia cell growth in nude mice].
    Zhao J; Chu J; Wang S; Xu S
    Zhonghua Xue Ye Xue Za Zhi; 2001 May; 22(5):229-31. PubMed ID: 11877075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of inhibition of cyclooxygenase-2 by RNA interference on proliferation and apoptosis of human gastric cancer cells: an experimental study with human gastric cancer cells and mice].
    Wang BH; Qian W; Gao YJ; Wang HF; Hou XH
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):266-71. PubMed ID: 16677508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic regulation of PRAME in acute myeloid leukemia is different compared to CD34+ cells from healthy donors: effect of 5-AZA treatment.
    Gutierrez-Cosío S; de la Rica L; Ballestar E; Santamaría C; Sánchez-Abarca LI; Caballero-Velazquez T; Blanco B; Calderón C; Herrero-Sánchez C; Carrancio S; Ciudad L; Cañizo C; San Miguel JF; Pérez-Simón JA
    Leuk Res; 2012 Jul; 36(7):895-9. PubMed ID: 22503131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The expression of PRAME in chronic lymphoproliferative disorders.
    Proto-Siqueira R; Falcão RP; de Souza CA; Ismael SJ; Zago MA
    Leuk Res; 2003 May; 27(5):393-6. PubMed ID: 12620290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypomethylation of PRAME is responsible for its aberrant overexpression in human malignancies.
    Schenk T; Stengel S; Goellner S; Steinbach D; Saluz HP
    Genes Chromosomes Cancer; 2007 Sep; 46(9):796-804. PubMed ID: 17534929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knockdown of NPM1 by RNA interference inhibits cells proliferation and induces apoptosis in leukemic cell line.
    Qin FX; Shao HY; Chen XC; Tan S; Zhang HJ; Miao ZY; Wang L; Hui-Chen ; Zhang L
    Int J Med Sci; 2011 Apr; 8(4):287-94. PubMed ID: 21537492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic regulation of PRAME gene in chronic myeloid leukemia.
    Roman-Gomez J; Jimenez-Velasco A; Agirre X; Castillejo JA; Navarro G; Jose-Eneriz ES; Garate L; Cordeu L; Cervantes F; Prosper F; Heiniger A; Torres A
    Leuk Res; 2007 Nov; 31(11):1521-8. PubMed ID: 17382387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.